10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 for the quarterly period ended December 31, 2021

OR

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 Commission File Number 0-3295

KOSS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

DELAWARE	39-1168275
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

4129 North Port Washington Avenue, Milwaukee, Wisconsin	53212
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (414) 964-5000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.005 per share	KOSS	Nasdaq Capital Market

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☑  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☑  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☑	Smaller reporting company ☑
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.).  Yes ☐ No ☑

At January 31, 2022, there were 9,147,795 shares outstanding of the registrant’s common stock. 

KOSS CORPORATION

FORM 10-Q

December 31, 2021

INDEX

			Page
PART I	FINANCIAL INFORMATION		3
	Item 1.	Financial Statements (Unaudited)	3
		Condensed Consolidated Balance Sheets as of December 31, 2021 and June 30, 2021	3
		Condensed Consolidated Statements of Income for the Three and Six Months Ended December 31, 2021 and 2020	4
		Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2021 and 2020	5
		Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended December 31, 2021 and 2020	6
		Notes to Condensed Consolidated Financial Statements	7
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	12
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	17
	Item 4.	Controls and Procedures	17
PART II	OTHER INFORMATION		17
	Item 1.	Legal Proceedings	17
	Item 1A.	Risk Factors	17
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	17
	Item 6.	Exhibits	19

 
‎

2

PART I

FINANCIAL INFORMATION

Item 1.    Financial Statements

KOSS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

	December 31, 2021		June 30, 2021
ASSETS
Current assets:
Cash and cash equivalents	$	7,788,804	$	6,950,215
Accounts receivable, less allowance for doubtful accounts of $5,736 and $41,499, respectively		1,458,066		2,240,785
Life insurance receivable		2,007,769		—
Inventories, net		7,746,449		5,901,512
Prepaid expenses and other current assets		470,561		456,004
Total current assets		19,471,649		15,548,516
Equipment and leasehold improvements, net		1,195,240		1,281,180
Other assets:
Operating lease right-of-use asset		2,162,513		2,305,455
Cash surrender value of life insurance		5,701,844		7,188,994
Total other assets		7,864,357		9,494,449
Total assets	$	28,531,246	$	26,324,145
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	866,195	$	398,433
Accrued liabilities		751,643		665,567
Deferred revenue		606,794		694,632
Operating lease liability		295,144		288,949
Income taxes payable		6,605		4,543
Total current liabilities		2,526,381		2,052,124
Long-term liabilities:
Deferred compensation		2,264,909		2,491,482
Deferred revenue		164,745		188,932
Operating lease liability		1,867,369		2,016,506
Total long-term liabilities		4,297,023		4,696,920
Total liabilities		6,823,404		6,749,044
Stockholders' equity:
Common stock, $0.005 par value, authorized 20,000,000 shares; issued and outstanding 9,147,795 and 8,608,706, respectively		45,739		43,044
Paid in capital		12,452,554		10,802,118
Retained earnings		9,209,549		8,729,939
Total stockholders' equity		21,707,842		19,575,101
Total liabilities and stockholders' equity	$	28,531,246	$	26,324,145

 The accompanying notes are an integral part of these condensed consolidated financial statements. 
‎

3

KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

	Three Months Ended				Six Months Ended
	December 31				December 31
	2021		2020		2021		2020
Net sales	$	4,415,886	$	4,929,789	$	8,780,953	$	10,138,084
Cost of goods sold		2,866,193		3,311,892		5,649,423		6,883,960
Gross profit		1,549,693		1,617,897		3,131,530		3,254,124
Selling, general and administrative expenses		1,229,294		1,615,824		3,010,091		3,121,595
Income from operations		320,399		2,073		121,439		132,529
Other income		255,975		506,700		355,975		506,700
Interest income		3,626		2,660		4,258		609
Income before income tax provision		580,000		511,433		481,672		639,838
Income tax provision		1,031		2,543		2,062		4,019
Net income	$	578,969	$	508,890	$	479,610	$	635,819
Income per common share:
Basic	$	0.06	$	0.07	$	0.05	$	0.09
Diluted	$	0.06	$	0.07	$	0.05	$	0.09
Weighted-average number of shares:
Basic		9,144,099		7,405,758		8,994,023		7,405,295
Diluted		10,064,713		7,453,450		10,062,915		7,424,239

The accompanying notes are an integral part of these condensed consolidated financial statements. 
‎

4

KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

	Six Months Ended
	December 31
	2021		2020
Operating activities:
Net income	$	479,610	$	635,819
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
(Recovery of) provision for doubtful accounts of accounts receivable		(35,764)		8,108
Depreciation of equipment and leasehold improvements		161,095		153,559
Stock-based compensation expense		262,785		309,756
Change in cash surrender value of life insurance		(168,756)		(158,521)
Provision for deferred compensation		167,560		58,000
Deferred compensation paid		(71,250)		(75,000)
Deferred compensation relieved		(472,883)		—
Other income - SBA loan forgiveness		—		(506,700)
Other income - Net gain from life insurance benefits		(255,975)		—
Net changes in operating assets and liabilities:
Accounts receivable		818,483		(234,090)
Inventories		(1,844,937)		(264,220)
Prepaid expenses and other current assets		(14,557)		(135,479)
Income taxes receivable		—		4,019
Income taxes payable		2,062		—
Accounts payable		467,762		282,535
Accrued liabilities		236,076		474,481
Deferred revenue		(112,025)		232,413
Net cash (used in) provided by operating activities		(380,714)		784,680
Investing activities:
Purchase of equipment and leasehold improvements		(75,155)		(374,558)
Life insurance premiums paid		(95,888)		(103,730)
Net cash (used in) investing activities		(171,043)		(478,288)
Financing activities:
Proceeds from exercise of stock options		1,390,346		88,918
Net cash provided by financing activities		1,390,346		88,918
Net increase in cash and cash equivalents		838,589		395,310
Cash and cash equivalents at beginning of period		6,950,215		3,999,409
Cash and cash equivalents at end of period	$	7,788,804	$	4,394,719
Non-cash financing and investing activity:
Reclassification of cash surrender value of life insurance to life insurance receivable	$	1,751,794	$	—

The accompanying notes are an integral part of these condensed consolidated financial statements. 
‎

5

KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

	Six Months Ended December 31, 2021
	Common Stock			Paid in		Retained
	Shares	Amount		Capital		Earnings		Total
Balance, June 30, 2021	8,608,706	$	43,044	$	10,802,118	$	8,729,939	$	19,575,101
Net income	—		—		—		479,610		479,610
Stock-based compensation expense	—		—		262,785		—		262,785
Stock option exercises	539,089		2,695		1,387,651		—		1,390,346
Balance, December 31, 2021	9,147,795	$	45,739	$	12,452,554	$	9,209,549	$	21,707,842

	Six Months Ended December 31, 2020
	Common Stock			Paid in		Retained
	Shares	Amount		Capital		Earnings		Total
Balance, June 30, 2020	7,404,831	$	37,024	$	6,882,729	$	8,236,345	$	15,156,098
Net income	—		—		—		635,819		635,819
Stock-based compensation expense	—		—		309,756		—		309,756
Stock option exercises	42,658		213		88,705		—		88,918
Balance, December 31, 2020	7,447,489	$	37,237	$	7,281,190	$	8,872,164	$	16,190,591

	Three Months Ended December 31, 2021
	Common Stock			Paid in		Retained
	Shares	Amount		Capital		Earnings		Total
Balance, September 30, 2021	9,137,795	$	45,689	$	12,302,395	$	8,630,580	$	20,978,664
Net income	—		—		—		578,969		578,969
Stock-based compensation expense	—		—		123,909		—		123,909
Stock option exercises	10,000		50		26,250		—		26,300
Balance, December 31, 2021	9,147,795	$	45,739	$	12,452,554	$	9,209,549	$	21,707,842

	Three Months Ended December 31, 2020
	Common Stock			Paid in		Retained
	Shares	Amount		Capital		Earnings		Total
Balance, September 30, 2020	7,404,831	$	37,024	$	7,035,723	$	8,363,274	$	15,436,021
Net income	—		—		—		508,890		508,890
Stock-based compensation expense	—		—		156,762		—		156,762
Stock option exercises	42,658		213		88,705		—		88,918
Balance, December 31, 2020	7,447,489	$	37,237	$	7,281,190	$	8,872,164	$	16,190,591

The accompanying notes are an integral part of these condensed consolidated financial statements.

 
‎

6

KOSS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2021

(Unaudited)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A)    BASIS OF PRESENTATION

The condensed consolidated balance sheets as of December 31, 2021 and June 30, 2021, the condensed consolidated statements of income for the three and six months ended December 31, 2021 and 2020, the condensed consolidated statements of cash flows for the six months ended December 31, 2021 and 2020, and the condensed consolidated statements of stockholders' equity for the three and six months ended December 31, 2021 and 2020, have been prepared by the Company in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and have not been audited.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for all periods presented have been made.  The operating results for any interim period are not necessarily indicative of the operating results that may be experienced for the full fiscal year.

Certain information and footnote disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP  have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021.

The preparation of financial statements in conformity with U.S. GAAP requires the company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses. Significant estimates and assumptions are used for, but are not limited to, allowances for doubtful accounts, reserves for excess and obsolete inventories, long-lived and intangible assets, income tax valuation allowance, non-cash stock-based compensation and deferred compensation. Actual results could differ from the Company's estimates.

B)    INCOME TAXES

A state tax provision of $1,031 and $2,062 was recorded for the three and six months ended December 31, 2021.  For the three and six months ended December 31, 2020, the state tax provision was $2,543 and $4,019, respectively. The federal income tax expense was zero for the three and six months ended December 31, 2021 and the three and six months ended December 31, 2020.

In the six months ended December 31, 2021, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense is expected to cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The tax loss carryforward for the year ending June 30, 2022, including the stock-based compensation expense deductions in the six months ended December 31, 2021, is expected to be approximately $39,800,000. The additional estimated tax loss carryforward increased the deferred tax asset to approximately $12,000,000 as of December 31, 2021, and the future realization of this is uncertain. The valuation allowance was increased to fully offset the deferred tax asset.

C) OTHER INCOME

In December 2021, the Company recognized approximately $256,000 of other income related to the proceeds from company-owned life insurance policies on its founder, who passed away on December 21, 2021.

In July 2021, the Company entered into a license agreement with a headphone manufacturer (whereby the manufacturer licensed the use of certain patents in certain of their headphones). The one-time license fee of $100,000 was also treated as other income. Other income is shown as a separate line on the condensed consolidated statement of income. There was a related payment of $100,000 to a third party that was charged to legal expense in the first quarter.

D) DEFERRED COMPENSATION

The Company’s deferred compensation liabilities are for a current and former officer and are calculated based on various assumptions which may include compensation, years of service, expected retirement date, discount rates, and mortality tables. The related expense is calculated using the net present value of the expected payments and is included in selling, general and administrative expenses in the Condensed Consolidated Statement of Operations. The Company’s current and non-current compensation obligations are included in accrued liabilities and deferred compensation, respectively, in the Condensed Consolidated Balance Sheets.

7

In December 2021, the Company’s founder and former officer passed away. The Company had a total deferred compensation liability of $472,883 recorded at June 30, 2021 related to the former officer, which at his death was relieved. Deferred compensation income of $472,883 was recognized in selling, general and administrative expenses as a result. Payments of $71,250 made under this arrangement during the six months ended December 31, 2021 were expensed as paid. The remaining deferred compensation liability of $2,264,909 and $2,168,599 recorded at December 31, 2021 and June 30, 2021, respectively, relates to the current officer’s plan. Deferred compensation expense of $45,000 and $96,310 was recognized under this arrangement in the three and six months ended December 31, 2021.

2.    INVENTORIES

The components of inventories were as follows:

	December 31, 2021		June 30, 2021
Raw materials	$	2,227,757	$	2,067,572
Finished goods		7,312,653		5,621,228
Inventories, gross		9,540,410		7,688,800
Reserve for obsolete inventory		(1,793,961)		(1,787,288)
Inventories, net	$	7,746,449	$	5,901,512

3.    CREDIT FACILITY AND SBA LOAN

On May 14, 2019, the Company entered into a secured credit facility ("Credit Agreement") with Town Bank (“Lender”). The Credit Agreement provides for a $5,000,000 revolving secured credit facility with an interest rate of 1.50% over LIBOR. The Credit Agreement also provides for letters of credit for the benefit of the Company of up to a sublimit of $1,000,000. There are no unused line fees in the credit facility. On January 28, 2021, the Credit Agreement was amended to extend the expiration to October 31, 2022, and to change the interest rate to Wall Street Journal Prime less 1.50%. The Company and the Lender also entered into a General Business Security Agreement dated May 14, 2019 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement. The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, disposition of assets, mergers and liquidations, among other restrictions. As of December 31, 2021, the Company was in material compliance with all covenants related to the Credit Agreement. As of December 31, 2021, and June 30, 2021, there were no outstanding borrowings on the facility. 

On April 13, 2020, the Company received an unsecured loan (the "SBA Loan") for $506,700 under the Small Business Administration ("SBA") Paycheck Protection Program (the “PPP”) of the CARES Act through Town Bank. On November 3, 2020, the Company was notified that the full principal amount of $506,700 had been forgiven and was recorded as other income in the accompanying condensed statements of income for the three and six months ended December 31, 2020.

‎

8

4.    REVENUE RECOGNITION

The Company disaggregates its net sales by geographical location as it believes it best depicts how the nature, timing and uncertainty of net sales and cash flows are affected by economic factors. The following table summarizes net sales by geographical location:

	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2021		2020		2021		2020
United States	$	3,191,867	$	3,652,303	$	6,003,559	$	7,598,576
Export		1,224,019		1,277,486		2,777,394		2,539,508
Net Sales	$	4,415,886	$	4,929,789	$	8,780,953	$	10,138,084

Deferred revenue relates primarily to consumer and customer warranties. These constitute future performance obligations and the Company defers revenue related to these future performance obligations. In the six months ended December 31, 2021 and 2020, the Company recognized revenue, which was included in the deferred revenue liability at the beginning of the periods, of $335,578 and $200,424, respectively, for performance obligations related to consumer and customer warranties.  The deferred revenue liability was $593,920 as of June 30, 2020. The Company estimates that the deferred revenue performance obligations are satisfied within one year to three years and therefore uses that same time frame for recognition of the deferred revenue.

5.    INCOME PER COMMON AND COMMON STOCK EQUIVALENT SHARE

Basic income per share is computed based on the weighted-average number of common shares outstanding.  Diluted income per common share is calculated assuming the exercise of stock options except where the result would be anti-dilutive.  The following table reconciles the numerator and denominator used to calculate basic and diluted income per share:

	Three Months Ended December 31,				Six Months Ended December 31,
	2021		2020		2021		2020
Numerator
Net income	$	578,969	$	508,890	$	479,610	$	635,819
Denominator
Weighted average shares, basic		9,144,099		7,405,758		8,994,023		7,405,295
Dilutive effect of stock compensation awards (1)		920,614		47,692		1,068,892		18,944
Diluted shares		10,064,713		7,453,450		10,062,915		7,424,239
Net income attributable to common shareholders per share:
Basic	$	0.06	$	0.07	$	0.05	$	0.09
Diluted	$	0.06	$	0.07	$	0.05	$	0.09

(1) Excludes approximately 2,490,061 and 2,564,584 weighted average stock options during the three and six months ended December 31, 2020, respectively, as the impact of such awards was anti-dilutive. For the three and six months ended December 31, 2021, no stock options were anti-dilutive.

6.    RELATED PARTY LEASE

The Company leases its facility in Milwaukee, Wisconsin from Koss Holdings, LLC, which is wholly-owned by the Company’s former Chairman’s revocable trust.  On January 5, 2017,  the lease was renewed for a period of five years, ending June 30, 2023, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year and included an option to renew at the same rate for an additional five years ending June 30, 2028.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.

7.    ACCOUNTS RECEIVABLE CONCENTRATIONS

As of December 31, 2021 the Company’s top three accounts receivable customers represented approximately 26%, 23%, and 13% of trade accounts receivables. These same customers represented approximately 24%, 19%, and 0% of trade accounts receivable at June 30, 2021.

9

8.    LEGAL MATTERS

As of December 31, 2021, the Company is involved in the matters described below:

• In July 2020, the Company filed complaints in United States District Court against each of Apple Inc., Bose Corporation, PEAG, LLC d/b/a JLab Audio, Plantronics, Inc. and Polycom, Inc., and Skullcandy, Inc. The complaints allege infringement on the Company’s patents relating to its wireless audio technology. In the event that a monetary award or judgment is received by the Company in connection with these complaints, all or portions of such amounts will be due to third parties. The Company does not expect to incur additional fees and costs related to these lawsuits that will have a material impact to its financial statements. Depending on the response to and the underlying results of the enforcement program, the Company may continue to litigate its claims, enter into licensing arrangements or reach some other outcome potentially advantageous to its competitive position.

• Early in fiscal year 2020, the Company was notified by One E-Way, Inc. that some of the Company's wireless products may infringe on certain One E-Way patents. No lawsuits involving these allegations have yet been filed and served on the Company.

The ultimate resolution of these matters is not determinable unless otherwise noted. We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving these claims against us, individually or in aggregate, will not have a material adverse impact on our Condensed Consolidated Financial Statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future.

‎

10

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements within the meaning of that term in the Private Securities Litigation Reform Act of 1995 (the “Act”) (Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).  Additional written or oral forward-looking statements may be made by the Company from time to time in filings with the Securities Exchange Commission, press releases, or otherwise.  Statements contained in this Form 10-Q that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Act.  Forward-looking statements may include, but are not limited to, projections of revenue, income or loss and capital expenditures, statements regarding future operations, anticipated financing needs, compliance with financial covenants in loan agreements, plans for acquisitions or sales of assets or businesses, plans relating to products or services of the Company, assessments of materiality, predictions of future events, the effects of pending and possible litigation and assumptions relating to the foregoing.  In addition, when used in this Form 10-Q, the words “aims,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “thinks,” “may,” “will,” “shall,” “should,” “could,” “would,” “forecasts,” “predicts,” “potential,” “continue” and variations thereof and similar expressions are intended to identify forward-looking statements.

Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified based on current expectations.  Consequently, future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements contained in this Form 10-Q, or in other Company filings, press releases, or otherwise.  In addition to the factors discussed in this Form 10-Q, other factors that could contribute to or cause such differences include, but are not limited to, developments in any one or more of the following areas: future fluctuations in economic conditions, the receptivity of consumers to new consumer electronics technologies, the rate and consumer acceptance of new product introductions, competition, pricing, the number and nature of customers and their product orders, production by third party vendors, foreign manufacturing, sourcing, and sales (including foreign government regulation, trade and importation concerns),  the effects of the COVID-19 pandemic on the economy and the Company’s operations, borrowing costs, changes in tax rates, pending or threatened litigation and investigations, and other risk factors described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and subsequently filed Quarterly Reports on Form 10-Q 

Readers are cautioned not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date hereof.  The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect new information.

 
‎

11

 Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

The Company developed stereo headphones in 1958 and has been recognized as a leader in the industry ever since. Koss markets a complete line of high-fidelity headphones, wireless Bluetooth® headphones, wireless Bluetooth® speakers, computer headsets, telecommunications headsets, and active noise canceling headphones. The Company operates as one business segment, as its principal business line is the design, manufacture and sale of stereo headphones and related accessories.

Financial Results

The following table presents selected financial data for the three and six months ended December 31, 2021 and 2020:

	Three Months Ended				Six Months Ended
	December 31				December 31
Financial Performance Summary	2021		2020		2021		2020
Net sales	$	4,415,886	$	4,929,789	$	8,780,953	$	10,138,084
Net sales (decrease) increase %		(10.4)%		18.4%		(13.4)%		5.9%
Gross profit	$	1,549,693	$	1,617,897	$	3,131,530	$	3,254,124
Gross profit as % of net sales		35.1%		32.8%		35.7%		32.1%
Selling, general and administrative expenses	$	1,229,294	$	1,615,824	$	3,010,091	$	3,121,595
Selling, general and administrative expenses as % of net sales		27.8%		32.8%		34.3%		30.8%
Interest income	$	3,626	$	2,660	$	4,258	$	609
Other income	$	255,975	$	506,700	$	355,975	$	506,700
Income before income tax provision	$	580,000	$	511,433	$	481,672	$	639,838
Income before income tax as % of net sales		13.1%		10.4%		5.5%		6.3%
Income tax provision	$	1,031	$	2,543	$	2,062	$	4,019
Income tax provision as % of income before income tax		0.2%		0.5%		0.4%		0.6%

‎

12

2021 Results Compared with 2020

(comments refer to both the three and six month periods ended December 31 unless otherwise noted)

For the three months and six ended December 31, 2021, net sales decreased 10.4% and 13.4%, respectively. The decrease in net sales was driven primarily by declines in the domestic markets.

Net sales in the domestic market were approximately $3,192,000 in the three months ended December 31, 2021, compared to approximately $3,652,000 in the prior year period. Domestic net sales for the six months ended December 31, 2021 were $6,004,000 compared to $7,599,000 for the same period in the prior year. Net sales to certain distrbutors were down as a result of a prior year surge in demand for communication headsets in the education market that did not continue at the same level in the current fiscal period. Also, the loss of sales to a mass retailer in the U.S. for a non Koss branded product impacted sales by $165,000 and $892,000, respectively, for the three and six months ended December 31, 2021. The final shipment of this product was during the quarter ended March 31, 2021. These net sales were at lower than normal margins. These declines were partially offset by growth in direct-to-consumer (DTC) sales.

Export net sales decreased slightly to approximately $1,224,000 for the three months ended December 31, 2021, compared to approximately $1,278,000 for the same period last year. Export sales were approximately $2,777,000 in the six months ended December 31, 2021 compared to approximately $2,539,000 in the prior year period. Sales to distributors in Europe were the primary drivers for the six month increase, mainly related to new products introduced in the last year.

Gross profit increased to 35.7% for the six months ended December 31, 2021, compared to 32.1% for the six months ended December 31, 2020.  Sales in the current year reflect a more favorable mix in both markets and products. The higher gross profit in the current year was due mainly to lost placement at a U.S. based mass retailer, which was low margin business, and increased, higher margin sales to DTC and distributors in the prison market. 

Late in the fiscal year ended June 30, 2021, the Company began experiencing increased delays in product shipments from suppliers in Asia. The worldwide disruption in ocean freight, as well as congestion at the ports on the U.S. west coast and domestic railyards, has caused delays and significantly increased inbound shipping costs. The higher shipping costs will negatively impact margins in the forseeable future.

Selling, general and administrative expenses for the three months ended December 31, 2021 decreased 23.9%, or approximately $387,000 to approximately $1,229,000.  The primary factor was the reversal of the deferred compensation liability of $472,000 for the Company’s founder who passed away in December 2021. This was partially offset by an increase in expenses related to information technology systems and services.

Other income for the three and six months ended December 31, 2021 was $256,000 and $356,000, respectively. In December 2021, the Company recognized other income on the proceeds from a company-owned life insurance policy on its founder, who passed away December 21, 2021. In July 2021, the Company recorded a one-time license fee of $100,000 related to a license agreement entered into with a headphone manufacturer whereby the manufacturer licensed the use of certain patents in certain of their headphones. A related payment of $100,000 to a third party was charged to legal expense. For the three and six months ended December 31, 2020, the Company recognized other income of $507,000 related to the forgiveness of an unsecured loan under the Small Business Administration Paycheck Protection Program of the CARES Act.

Income tax expense for the three and six months ended December 31, 2021 was comprised of the U.S. federal statutory rate of 21% and the effect of state income taxes offset by an adjustment to the valuation allowance for deferred tax assets. The effective tax rate was less than 1% in the three and six months ended December 31, 2021 and 2020. It is anticipated that the effective rate in the current year and future years will be reduced by utilization of a portion or all of the federal net operating loss carryforwards that existed as of June 30, 2021, plus the additional federal net operating loss carryforward generated by the deductible compensation expense on stock option exercises for the six months ended December 31, 2021.

In the six months ended December 31, 2021, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense will cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The expected federal tax loss carryforward, including the stock-based compensation expense deductions in the six months ended December 31, 2021, will be approximately $39,800,000. The additional estimated tax loss carryforward increased the deferred tax asset to approximately $12,000,000 as of December 31, 2021, and the future realization of this is uncertain. The valuation allowance was increased to fully offset the deferred tax asset.

‎

13

As previously reported, the Company maintains a program focused on enforcing its intellectual property and, in particular, certain of its patent portfolio. The Company has enforced its intellectual property by filing complaints against certain parties alleging infringement on the Company’s patents relating to its wireless headphone technology. If the program is successful, the Company may receive royalties, offers to purchase its intellectual property, or other remedies advantageous to its competitive position; however, there is no guarantee of a positive outcome from these efforts, which could ultimately be time consuming and unsuccessful. Additionally, in the event that a monetary award or judgment is received by the Company in connection with these complaints, all or portions of such amounts will be due to third parties.

The Company believes that its financial position remains strong. The Company had $7.8 million of cash and cash equivalents and available credit facilities of $5.0 million at December 31, 2021. 

‎

14

COVID-19 Impact

The Company has been closely monitoring the COVID-19 situation to protect the health and safety of its employees and customers.  Business plans are being continuously updated and executed to maintain supply of the Company’s products to our customers throughout the world.

Even though much of the population has returned to working from home and studying online due to recent COVID-19 related directives, the Company did not see the surge in the sale of specific communication headsets in the six months ended December 31, 2021 that occured in the same period in the prior year. Also, certain retail businesses throughout the Company’s markets, particularly in certain European markets, have seen continued disruption.  The Company expects the negative sales impacts caused by this disruption to continue until markets re-open and consumer spending returns to normal. 

The ultimate magnitude of the COVID-19 pandemic, including the extent of its impact on the Company’s business, financial position, results of operations or liquidity, cannot be reasonably estimated at this time due to the rapid development and fluidity of the situation. The Company's future results will be determined by the effectiveness of vaccines, rollout of vaccine boosters, the duration of the pandemic, impact of variants, its geographic spread, further business disruptions and the overall impact on the economy throughout the globe.

The Company’s supply chain is primarily in southern China.  Beginning in fiscal year 2021, the Company has experienced issues related to the availability of containers and routing to move products in a cost effective and time efficient manner. There have also been impacts to the movement of new product introductions and costs. The Company is monitoring the situation closely and the supply chain team has modified business plans, which include, but are not limited to: (1) increasing the investment in inventory; (2) being alert to potential short supply situations; (3) assisting suppliers with acquisition of critical components; and (4) utilizing alternative sources and/or air freight. 

To protect the safety, health and well-being of employees, customers, and suppliers, the Company continues to implement several preventive measures while also meeting the needs of global customers. They include increased frequency of cleaning and disinfecting of facilities, social distancing practices, remote working when possible, restrictions on business travel, holding certain events virtually and limitations on visitor access to facilities.

The Company is committed to continuing to execute these plans and will remain in close contact with its supply chain to monitor future possible implications, especially on production facilities.

Liquidity and Capital Resources

Cash Flows

The following table summarizes cash flows from operating, investing and financing activities for the six months ended December 31, 2021 and 2020:

Total cash provided by (used in):	2021		2020
Operating activities	$	(380,714)	$	784,680
Investing activities		(171,043)		(478,288)
Financing activities		1,390,346		88,918
Net increase in cash and cash equivalents	$	838,589	$	395,310

Operating Activities

The investment in inventories was the driving factor for the increase in cash used by operating activities during the six months ended December 31, 2021.  The Company has increased investment in inventory to ensure availability and to provide better inventory positions on key products to mitigate the impacts of supply chain disruptions. The impact of the investment in inventory was partially offset by a decrease in accounts receivable, as a result of lower sales, and increased accounts payable related to the inventory investment. The cash used by operating activities in the three and six months ended December 31, 2021 also included a net gain on a life insurance policy held on the Company’s founder, who passed away in December 2021.

‎

15

Investing Activities

Cash used in investing activities for the six months ended December 31, 2021 was lower than the same period in the prior year. In the prior year, the Company had increased expenditures for a new operating system and leasehold improvements. The Company expects to generate sufficient cash flow from operations or from the use of its available cash and its credit facility to fund any necessary tooling, leasehold improvement and capital expenditures.

Financing Activities

In the six months ended December 31, 2021, an aggregate of 539,089 shares of common stock were issued as a result of employee stock option exercises under the Company’s 2012 Omnibus Incentive Plan. The cash provided from these stock option exercises was approximately $1.4 million. An aggregate of 42,658 shares of common stock were issued as a result of employee stock option exercises under the Company’s 2012 Omnibus Incentive Plan in the six months ended December 31, 2020. The cash provided from these stock option exercises was approximately $89,000.

As of December 31, 2021, the Company had no outstanding borrowings on its bank line of credit facility. 

There were no purchases of common stock in the quarters ended December 31, 2021 or 2020 under the stock repurchase program. 

Liquidity

The Company's capital expenditures are primarily for leasehold improvements and tooling. In addition, it has interest payments on its borrowings when it uses its line of credit facility. The Company believes that cash generated from operations, together with cash reserves and available borrowings, provide it with adequate liquidity to meet operating requirements, debt service requirements and planned capital expenditures for the next twelve months following the date of this Quarterly Report on Form 10-Q and thereafter for the foreseeable future. The Company regularly evaluates new product offerings, inventory levels and capital expenditures to ensure that it is effectively allocating resources in line with current market conditions.

Credit Facility

On May 14, 2019, the Company entered into a secured credit facility ("Credit Agreement") with Town Bank (“Lender”). The Credit Agreement provides for a $5,000,000 revolving secured credit facility with an interest rate of 1.50% over LIBOR. The Credit Agreement also provides for letters of credit for the benefit of the Company of up to a sublimit of $1,000,000. There are no unused line fees in the credit facility. On January 28, 2021, the Credit Agreement was amended to extend the expiration to October 31, 2022, and to change the interest rate to Wall Street Journal Prime less 1.50%. The Company and the Lender also entered into a General Business Security Agreement dated May 14, 2019 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement. The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, disposition of assets, mergers and liquidations, among other restrictions. The Company is currently in material compliance with all covenants related to the Credit Agreement. As of December 31, 2021, and June 30, 2021, there were no outstanding borrowings on the facility. 

Contractual Obligation

The Company leases its facility in Milwaukee, Wisconsin from Koss Holdings, LLC, which is wholly-owned by the Company’s former Chairman’s revocable trust.  On January 5, 2017, the lease was renewed for a period of five years, ending June 30, 2023, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year and included an option to renew at the same rate for an additional five years ending June 30, 2028.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.

Off-Balance Sheet Transactions

At December 31, 2021, the Company did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.

‎

16

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Not applicable. 

Item 4.    Controls and Procedures

Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are designed to ensure that: (1) information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (2)  such information is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.  There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures.  Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

The Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2021.  The Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures as of December 31, 2021 were effective.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II

OTHER INFORMATION

Item 1.    Legal Proceedings

From time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. During the period covered by this report, there were no material changes to the description of legal proceedings set forth in Part I, Item 3 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2021.  

Item 1A.    Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed below and under Part 1. Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021, as filed with the Securities and Exchange Commission on August 20, 2021. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report. There have been no material changes to the risk factors described under “Risk Factors,” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021.   

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents information with respect to purchases of common stock of the Company made during the three months ended December 31, 2021, by the Company.

‎

17

COMPANY REPURCHASES OF EQUITY SECURITIES

	Total # of ‎Shares ‎Purchased	Average ‎Price Paid ‎per Share		Total Number of Shares Purchased as ‎Part of Publicly Announced Plan (1)	Approximate Dollar Value of ‎Shares Available under Repurchase Plan
October 1 - December 31, 2021	—	$	—	—	$	2,139,753

(1)In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account. Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program. The most recent increase was for an additional $2,000,000 in October 2006, for a maximum of $45,500,000 of which $43,360,247 had been expended through December 31, 2021.  

‎

18

Item 6.    Exhibits

Exhibit No.	Exhibit Description
3.1	Amended and Restated Certificate of Incorporation of Koss Corporation, as in effect on November 19, 2009. Filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2009 and incorporated herein by reference.
3.2	By-Laws of Koss Corporation. Filed as Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the year ended June 30, 1996 and incorporated herein by reference.
3.3	Amendment to the By-Laws of Koss Corporation. Filed as Exhibit 3.3 to the Company’s Current Report on Form 8-K on March 7, 2006 and incorporated herein by reference.
3.4	Amendment to the By-Laws of Koss Corporation. Filed as Exhibit 3.4 to the Company’s Annual Report on Form 10-K on August 27, 2020 and incorporated herein by reference.
31.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer *
31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer *
32.1	Section 1350 Certification of Chief Executive Officer **
32.2	Section 1350 Certification of Chief Financial Officer **
101	The following financial information from Koss Corporation's Quarterly Report on Form 10-Q for the quarter ended December 31, 2021, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of December 31, 2021 and June 30, 2021, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three and six months ended December 31, 2021 and 2020 (iii) Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended December 31, 2021 and 2020, (iv) Condensed Consolidated Statements of Stockholders' Equity (Unaudited) for the three and six months ended December 31, 2021 and 2020 and (v) the Notes to Condensed Consolidated Financial Statements (Unaudited). *

__________________________

*    Filed herewith

**  Furnished herewith

 
‎

19

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

KOSS CORPORATION
/s/ Michael J. Koss	February 4, 2022
Michael J. Koss
Chairman
Chief Executive Officer
/s/ David D. Smith	February 4, 2022
David D. Smith
Chief Financial Officer
Principal Accounting Officer

20

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael J. Koss, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Koss Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February4, 2022

/s/ Michael J. Koss

Michael J. Koss

Chairman and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David D. Smith, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Koss Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February4, 2022

/s/ David D. Smith

David D. Smith

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,

18 U.S.C. Section 1350

I, Michael J. Koss, Chief Executive Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended December  31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael J. Koss

Michael J. Koss

Chairman and Chief Executive Officer

Dated: February4, 2022

Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 

18 U.S.C. Section 1350

I, David D. Smith, Chief Financial Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended December  31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David D. Smith

David D. Smith

Chief Financial Officer

Dated: February4, 2022

Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Document Information Statement - shares	6 Months Ended
	Dec. 31, 2021	Jan. 31, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--06-30
Document Transition Report	false
Entity File Number	0-3295
Entity Registrant Name	KOSS CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	4129 North Port Washington Avenue
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Tax Identification Number	39-1168275
Entity Address, Postal Zip Code	53212
City Area Code	414
Local Phone Number	964-5000
Title of 12(b) Security	Common Stock, par value $0.005 per share
Trading Symbol	KOSS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,147,795
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000056701
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Current assets:
Cash and cash equivalents	$ 7,788,804	$ 6,950,215
Accounts receivable, less allowance for doubtful accounts of $5,736 and $41,499, respectively	1,458,066	2,240,785
Life insurance receivable	2,007,769
Inventories, net	7,746,449	5,901,512
Prepaid expenses and other current assets	470,561	456,004
Total current assets	19,471,649	15,548,516
Equipment and leasehold improvements, net	1,195,240	1,281,180
Other assets:
Operating lease right-of-use assets	2,162,513	2,305,455
Cash surrender value of life insurance	5,701,844	7,188,994
Total other assets	7,864,357	9,494,449
Total assets	28,531,246	26,324,145
Current liabilities:
Accounts payable	866,195	398,433
Accrued liabilities	751,643	665,567
Deferred revenue	606,794	694,632
Operating lease liability	295,144	288,949
Income taxes payable	6,605	4,543
Total current liabilities	2,526,381	2,052,124
Long-term liabilities:
Deferred compensation	2,264,909	2,491,482
Deferred revenue	164,745	188,932
Operating lease liability	1,867,369	2,016,506
Total long-term liabilities	4,297,023	4,696,920
Total liabilities	6,823,404	6,749,044
Stockholders' equity:
Common stock, $0.005 par value, authorized 20,000,000 shares; issued and outstanding 9,137,795 and 8,608,706, respectively	45,739	43,044
Paid in capital	12,452,554	10,802,118
Retained earnings	9,209,549	8,729,939
Total stockholders' equity	21,707,842	19,575,101
Total liabilities and stockholders' equity	$ 28,531,246	$ 26,324,145

XML

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 5,736	$ 41,499
Common stock, par value (in dollars per share)	$ 0.005	$ 0.005
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	9,147,795	8,608,706
Common stock, shares outstanding (in shares)	9,147,795	8,608,706

XML

Condensed Consolidated Statements of Income - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Condensed Consolidated Statements of Income [Abstract]
Net sales	$ 4,415,886	$ 4,929,789	$ 8,780,953	$ 10,138,084
Cost of goods sold	2,866,193	3,311,892	5,649,423	6,883,960
Gross profit	1,549,693	1,617,897	3,131,530	3,254,124
Selling, general and administrative expenses	1,229,294	1,615,824	3,010,091	3,121,595
Income from operations	320,399	2,073	121,439	132,529
Other income	255,975	506,700	355,975	506,700
Interest income	3,626	2,660	4,258	609
Income before income tax provision	580,000	511,433	481,672	639,838
Income tax provision	1,031	2,543	2,062	4,019
Net income	$ 578,969	$ 508,890	$ 479,610	$ 635,819
Income per common share:
Basic (in dollars per share)	$ 0.06	$ 0.07	$ 0.05	$ 0.09
Diluted (in dollars per share)	$ 0.06	$ 0.07	$ 0.05	$ 0.09
Weighted-average number of shares:
Basic (in shares)	9,144,099	7,405,758	8,994,023	7,405,295
Diluted (in shares)	10,064,713	7,453,450	10,062,915	7,424,239

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income	$ 479,610	$ 635,819
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
(Recovery of) provision for doubtful accounts of accounts receivable	(35,764)	8,108
Depreciation of equipment and leasehold improvements	161,095	153,559
Stock-based compensation expense	262,785	309,756
Change in cash surrender value of life insurance	(168,756)	(158,521)
Provision for deferred compensation	167,560	58,000
Deferred compensation paid	(71,250)	(75,000)
Deferred compensation relieved	(472,883)
Other income - SBA loan forgiveness		(506,700)
Other income - Net gain from life insurance benefits	(255,975)
Net changes in operating assets and liabilities:
Accounts receivable	818,483	(234,090)
Inventories	(1,844,937)	(264,220)
Prepaid expenses and other current assets	(14,557)	(135,479)
Income taxes receivable		4,019
Income taxes payable	2,062
Accounts payable	467,762	282,535
Accrued liabilities	236,076	474,481
Deferred revenue	(112,025)	232,413
Net cash (used in) provided by operating activities	(380,714)	784,680
Investing activities:
Purchase of equipment and leasehold improvements	(75,155)	(374,558)
Life insurance premiums paid	(95,888)	(103,730)
Net cash (used in) investing activities	(171,043)	(478,288)
Financing activities:
Proceeds from exercise of stock options	1,390,346	88,918
Net cash provided by financing activities	1,390,346	88,918
Net increase in cash and cash equivalents	838,589	395,310
Cash and cash equivalents at beginning of period	6,950,215	3,999,409
Cash and cash equivalents at end of period	7,788,804	$ 4,394,719
Non-cash financing and investing activity:
Reclassification of cash surrender value of life insurance to life insurance receivable	$ 1,751,794

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock [Member]	Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Jun. 30, 2020	7,404,831
Balance at Jun. 30, 2020	$ 37,024	$ 6,882,729	$ 8,236,345	$ 15,156,098
Net income			635,819	635,819
Stock-based compensation expense		309,756		309,756
Stock option exercises (in shares)	42,658
Stock option exercises	$ 213	88,705		88,918
Balance at Dec. 31, 2020	$ 37,237	7,281,190	8,872,164	16,190,591
Balance (in shares) at Dec. 31, 2020	7,447,489
Balance (in shares) at Sep. 30, 2020	7,404,831
Balance at Sep. 30, 2020	$ 37,024	7,035,723	8,363,274	15,436,021
Net income			508,890	508,890
Stock-based compensation expense		156,762		156,762
Stock option exercises (in shares)	42,658
Stock option exercises	$ 213	88,705		88,918
Balance at Dec. 31, 2020	$ 37,237	7,281,190	8,872,164	$ 16,190,591
Balance (in shares) at Dec. 31, 2020	7,447,489
Balance (in shares) at Jun. 30, 2021	8,608,706			8,608,706
Balance at Jun. 30, 2021	$ 43,044	10,802,118	8,729,939	$ 19,575,101
Net income			479,610	479,610
Stock-based compensation expense		262,785		262,785
Stock option exercises (in shares)	539,089
Stock option exercises	$ 2,695	1,387,651		1,390,346
Balance at Dec. 31, 2021	$ 45,739	12,452,554	9,209,549	$ 21,707,842
Balance (in shares) at Dec. 31, 2021	9,147,795			9,147,795
Balance (in shares) at Sep. 30, 2021	9,137,795
Balance at Sep. 30, 2021	$ 45,689	12,302,395	8,630,580	$ 20,978,664
Net income			578,969	578,969
Stock-based compensation expense		123,909		123,909
Stock option exercises (in shares)	10,000
Stock option exercises	$ 50	26,250		26,300
Balance at Dec. 31, 2021	$ 45,739	$ 12,452,554	$ 9,209,549	$ 21,707,842
Balance (in shares) at Dec. 31, 2021	9,147,795			9,147,795

XML

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A)    BASIS OF PRESENTATION The condensed consolidated balance sheets as of December 31, 2021 and June 30, 2021, the condensed consolidated statements of income for the three and six months ended December 31, 2021 and 2020, the condensed consolidated statements of cash flows for the six months ended December 31, 2021 and 2020, and the condensed consolidated statements of stockholders' equity for the three and six months ended December 31, 2021 and 2020, have been prepared by the Company in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and have not been audited.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for all periods presented have been made.  The operating results for any interim period are not necessarily indicative of the operating results that may be experienced for the full fiscal year. Certain information and footnote disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP  have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021. The preparation of financial statements in conformity with U.S. GAAP requires the company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses. Significant estimates and assumptions are used for, but are not limited to, allowances for doubtful accounts, reserves for excess and obsolete inventories, long-lived and intangible assets, income tax valuation allowance, non-cash stock-based compensation and deferred compensation. Actual results could differ from the Company's estimates.  B)    INCOME TAXES A state tax provision of $1,031 and $2,062 was recorded for the three and six months ended December 31, 2021.  For the three and six months ended December 31, 2020, the state tax provision was $2,543 and $4,019, respectively. The federal income tax expense was zero for the three and six months ended December 31, 2021 and the three and six months ended December 31, 2020. In the six months ended December 31, 2021, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense is expected to cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The tax loss carryforward for the year ending June 30, 2022, including the stock-based compensation expense deductions in the six months ended December 31, 2021, is expected to be approximately $39,800,000. The additional estimated tax loss carryforward increased the deferred tax asset to approximately $12,000,000 as of December 31, 2021, and the future realization of this is uncertain. The valuation allowance was increased to fully offset the deferred tax asset. C) OTHER INCOME In December 2021, the Company recognized approximately $256,000 of other income related to the proceeds from company-owned life insurance policies on its founder, who passed away on December 21, 2021. In July 2021, the Company entered into a license agreement with a headphone manufacturer (whereby the manufacturer licensed the use of certain patents in certain of their headphones). The one-time license fee of $100,000 was also treated as other income. Other income is shown as a separate line on the condensed consolidated statement of income. There was a related payment of $100,000 to a third party that was charged to legal expense in the first quarter. D) DEFERRED COMPENSATION The Company’s deferred compensation liabilities are for a current and former officer and are calculated based on various assumptions which may include compensation, years of service, expected retirement date, discount rates, and mortality tables. The related expense is calculated using the net present value of the expected payments and is included in selling, general and administrative expenses in the Condensed Consolidated Statement of Operations. The Company’s current and non-current compensation obligations are included in accrued liabilities and deferred compensation, respectively, in the Condensed Consolidated Balance Sheets. In December 2021, the Company’s founder and former officer passed away. The Company had a total deferred compensation liability of $472,883 recorded at June 30, 2021 related to the former officer, which at his death was relieved. Deferred compensation income of $472,883 was recognized in selling, general and administrative expenses as a result. Payments of $71,250 made under this arrangement during the six months ended December 31, 2021 were expensed as paid. The remaining deferred compensation liability of $2,264,909 and $2,168,599 recorded at December 31, 2021 and June 30, 2021, respectively, relates to the current officer’s plan. Deferred compensation expense of $45,000 and $96,310 was recognized under this arrangement in the three and six months ended December 31, 2021.

XML

Inventories	6 Months Ended
	Dec. 31, 2021
Inventories [Abstract]
Inventories	2.    INVENTORIES The components of inventories were as follows:  December 31, 2021 June 30, 2021Raw materials$ 2,227,757 $ 2,067,572Finished goods 7,312,653 5,621,228Inventories, gross 9,540,410 7,688,800Reserve for obsolete inventory (1,793,961) (1,787,288)Inventories, net$ 7,746,449 $ 5,901,512

XML

Credit Facility and SBA Loan	6 Months Ended
	Dec. 31, 2021
Credit Facility and SBA Loan [Abstract]
Credit Facility and SBA Loan	3.    CREDIT FACILITY AND SBA LOAN On May 14, 2019, the Company entered into a secured credit facility ("Credit Agreement") with Town Bank (“Lender”). The Credit Agreement provides for a $5,000,000 revolving secured credit facility with an interest rate of 1.50% over LIBOR. The Credit Agreement also provides for letters of credit for the benefit of the Company of up to a sublimit of $1,000,000. There are no unused line fees in the credit facility. On January 28, 2021, the Credit Agreement was amended to extend the expiration to October 31, 2022, and to change the interest rate to Wall Street Journal Prime less 1.50%. The Company and the Lender also entered into a General Business Security Agreement dated May 14, 2019 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement. The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, disposition of assets, mergers and liquidations, among other restrictions. As of December 31, 2021, the Company was in material compliance with all covenants related to the Credit Agreement. As of December 31, 2021, and June 30, 2021, there were no outstanding borrowings on the facility.  On April 13, 2020, the Company received an unsecured loan (the "SBA Loan") for $506,700 under the Small Business Administration ("SBA") Paycheck Protection Program (the “PPP”) of the CARES Act through Town Bank. On November 3, 2020, the Company was notified that the full principal amount of $506,700 had been forgiven and was recorded as other income in the accompanying condensed statements of income for the three and six months ended December 31, 2020.  ‎

XML

Revenue Recognition	6 Months Ended
	Dec. 31, 2021
Revenue Recognition [Abstract]
Revenue Recognition	4.    REVENUE RECOGNITION The Company disaggregates its net sales by geographical location as it believes it best depicts how the nature, timing and uncertainty of net sales and cash flows are affected by economic factors. The following table summarizes net sales by geographical location:  Three Months Ended Six Months Ended December 31, December 31, 2021 2020 2021 2020United States$ 3,191,867 $ 3,652,303 $ 6,003,559 $ 7,598,576Export 1,224,019 1,277,486 2,777,394 2,539,508Net Sales$ 4,415,886 $ 4,929,789 $ 8,780,953 $ 10,138,084 Deferred revenue relates primarily to consumer and customer warranties. These constitute future performance obligations and the Company defers revenue related to these future performance obligations. In the six months ended December 31, 2021 and 2020, the Company recognized revenue, which was included in the deferred revenue liability at the beginning of the periods, of $335,578 and $200,424, respectively, for performance obligations related to consumer and customer warranties.  The deferred revenue liability was $593,920 as of June 30, 2020. The Company estimates that the deferred revenue performance obligations are satisfied within one year to three years and therefore uses that same time frame for recognition of the deferred revenue.

XML

(Loss) Income Per Common and Common Stock Equivalent Share	6 Months Ended
	Dec. 31, 2021
(Loss) Income Per Common and Common Stock Equivalent Share [Abstract]
(Loss) Income Per Common and Common Stock Equivalent Share	5.    INCOME PER COMMON AND COMMON STOCK EQUIVALENT SHARE Basic income per share is computed based on the weighted-average number of common shares outstanding.  Diluted income per common share is calculated assuming the exercise of stock options except where the result would be anti-dilutive.  The following table reconciles the numerator and denominator used to calculate basic and diluted income per share: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020Numerator Net income$ 578,969 $ 508,890 $ 479,610 $ 635,819 Denominator Weighted average shares, basic 9,144,099 7,405,758 8,994,023 7,405,295Dilutive effect of stock compensation awards (1) 920,614 47,692 1,068,892 18,944Diluted shares 10,064,713 7,453,450 10,062,915 7,424,239 Net income attributable to common shareholders per share: Basic$ 0.06 $ 0.07 $ 0.05 $ 0.09Diluted$ 0.06 $ 0.07 $ 0.05 $ 0.09 (1) Excludes approximately 2,490,061 and 2,564,584 weighted average stock options during the three and six months ended December 31, 2020, respectively, as the impact of such awards was anti-dilutive. For the three and six months ended December 31, 2021, no stock options were anti-dilutive.

XML

Related Party Leases	6 Months Ended
	Dec. 31, 2021
Related Party Leases [Abstract]
Related Party Leases	6.    RELATED PARTY LEASE The Company leases its facility in Milwaukee, Wisconsin from Koss Holdings, LLC, which is wholly-owned by the Company’s former Chairman’s revocable trust.  On January 5, 2017,  the lease was renewed for a period of five years, ending June 30, 2023, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year and included an option to renew at the same rate for an additional five years ending June 30, 2028.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.

XML

Accounts Receivable Concentrations	6 Months Ended
	Dec. 31, 2021
Accounts Receivable Concentrations [Abstract]
Accounts Receivable Concentrations	7.    ACCOUNTS RECEIVABLE CONCENTRATIONS As of December 31, 2021 the Company’s top three accounts receivable customers represented approximately 26%, 23%, and 13% of trade accounts receivables. These same customers represented approximately 24%, 19%, and 0% of trade accounts receivable at June 30, 2021.

XML

Legal Matters	6 Months Ended
	Dec. 31, 2021
Legal Matters [Abstract]
Legal Matters	8.    LEGAL MATTERS As of December 31, 2021, the Company is involved in the matters described below: • In July 2020, the Company filed complaints in United States District Court against each of Apple Inc., Bose Corporation, PEAG, LLC d/b/a JLab Audio, Plantronics, Inc. and Polycom, Inc., and Skullcandy, Inc. The complaints allege infringement on the Company’s patents relating to its wireless audio technology. In the event that a monetary award or judgment is received by the Company in connection with these complaints, all or portions of such amounts will be due to third parties. The Company does not expect to incur additional fees and costs related to these lawsuits that will have a material impact to its financial statements. Depending on the response to and the underlying results of the enforcement program, the Company may continue to litigate its claims, enter into licensing arrangements or reach some other outcome potentially advantageous to its competitive position. • Early in fiscal year 2020, the Company was notified by One E-Way, Inc. that some of the Company's wireless products may infringe on certain One E-Way patents. No lawsuits involving these allegations have yet been filed and served on the Company. The ultimate resolution of these matters is not determinable unless otherwise noted. We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving these claims against us, individually or in aggregate, will not have a material adverse impact on our Condensed Consolidated Financial Statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future.

XML

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	A)    BASIS OF PRESENTATION The condensed consolidated balance sheets as of December 31, 2021 and June 30, 2021, the condensed consolidated statements of income for the three and six months ended December 31, 2021 and 2020, the condensed consolidated statements of cash flows for the six months ended December 31, 2021 and 2020, and the condensed consolidated statements of stockholders' equity for the three and six months ended December 31, 2021 and 2020, have been prepared by the Company in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and have not been audited.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for all periods presented have been made.  The operating results for any interim period are not necessarily indicative of the operating results that may be experienced for the full fiscal year. Certain information and footnote disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP  have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021. The preparation of financial statements in conformity with U.S. GAAP requires the company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses. Significant estimates and assumptions are used for, but are not limited to, allowances for doubtful accounts, reserves for excess and obsolete inventories, long-lived and intangible assets, income tax valuation allowance, non-cash stock-based compensation and deferred compensation. Actual results could differ from the Company's estimates.
Income Taxes	B)    INCOME TAXES A state tax provision of $1,031 and $2,062 was recorded for the three and six months ended December 31, 2021.  For the three and six months ended December 31, 2020, the state tax provision was $2,543 and $4,019, respectively. The federal income tax expense was zero for the three and six months ended December 31, 2021 and the three and six months ended December 31, 2020. In the six months ended December 31, 2021, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense is expected to cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The tax loss carryforward for the year ending June 30, 2022, including the stock-based compensation expense deductions in the six months ended December 31, 2021, is expected to be approximately $39,800,000. The additional estimated tax loss carryforward increased the deferred tax asset to approximately $12,000,000 as of December 31, 2021, and the future realization of this is uncertain. The valuation allowance was increased to fully offset the deferred tax asset.
Other Income	C) OTHER INCOME In December 2021, the Company recognized approximately $256,000 of other income related to the proceeds from company-owned life insurance policies on its founder, who passed away on December 21, 2021. In July 2021, the Company entered into a license agreement with a headphone manufacturer (whereby the manufacturer licensed the use of certain patents in certain of their headphones). The one-time license fee of $100,000 was also treated as other income. Other income is shown as a separate line on the condensed consolidated statement of income. There was a related payment of $100,000 to a third party that was charged to legal expense in the first quarter.
Deferred Compensation	D) DEFERRED COMPENSATION The Company’s deferred compensation liabilities are for a current and former officer and are calculated based on various assumptions which may include compensation, years of service, expected retirement date, discount rates, and mortality tables. The related expense is calculated using the net present value of the expected payments and is included in selling, general and administrative expenses in the Condensed Consolidated Statement of Operations. The Company’s current and non-current compensation obligations are included in accrued liabilities and deferred compensation, respectively, in the Condensed Consolidated Balance Sheets. In December 2021, the Company’s founder and former officer passed away. The Company had a total deferred compensation liability of $472,883 recorded at June 30, 2021 related to the former officer, which at his death was relieved. Deferred compensation income of $472,883 was recognized in selling, general and administrative expenses as a result. Payments of $71,250 made under this arrangement during the six months ended December 31, 2021 were expensed as paid. The remaining deferred compensation liability of $2,264,909 and $2,168,599 recorded at December 31, 2021 and June 30, 2021, respectively, relates to the current officer’s plan. Deferred compensation expense of $45,000 and $96,310 was recognized under this arrangement in the three and six months ended December 31, 2021.

XML

Inventories (Tables)	6 Months Ended
	Dec. 31, 2021
Inventories [Abstract]
Components of Inventories	December 31, 2021 June 30, 2021Raw materials$ 2,227,757 $ 2,067,572Finished goods 7,312,653 5,621,228Inventories, gross 9,540,410 7,688,800Reserve for obsolete inventory (1,793,961) (1,787,288)Inventories, net$ 7,746,449 $ 5,901,512

XML

Revenue Recognition (Tables)	6 Months Ended
	Dec. 31, 2021
Revenue Recognition [Abstract]
Disaggregation of Revenue	Three Months Ended Six Months Ended December 31, December 31, 2021 2020 2021 2020United States$ 3,191,867 $ 3,652,303 $ 6,003,559 $ 7,598,576Export 1,224,019 1,277,486 2,777,394 2,539,508Net Sales$ 4,415,886 $ 4,929,789 $ 8,780,953 $ 10,138,084

XML

(Loss) Income Per Common and Common Stock Equivalent Sharee (Tables)	6 Months Ended
	Dec. 31, 2021
(Loss) Income Per Common and Common Stock Equivalent Share [Abstract]
(Loss) Income Per Common and Common Stock Equivalent Share	Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020Numerator Net income$ 578,969 $ 508,890 $ 479,610 $ 635,819 Denominator Weighted average shares, basic 9,144,099 7,405,758 8,994,023 7,405,295Dilutive effect of stock compensation awards (1) 920,614 47,692 1,068,892 18,944Diluted shares 10,064,713 7,453,450 10,062,915 7,424,239 Net income attributable to common shareholders per share: Basic$ 0.06 $ 0.07 $ 0.05 $ 0.09Diluted$ 0.06 $ 0.07 $ 0.05 $ 0.09 (1) Excludes approximately 2,490,061 and 2,564,584 weighted average stock options during the three and six months ended December 31, 2020, respectively, as the impact of such awards was anti-dilutive. For the three and six months ended December 31, 2021, no stock options were anti-dilutive.

XML

Summary of Significant Accounting Policies (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jul. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Operating Loss Carryforwards [Line Items]
Other income - Net gain from life insurance benefits	$ 256,000				$ 255,975
Income Tax Expense (Benefit)			$ 1,031	$ 2,543	2,062	$ 4,019
Share based tax expense					8,000,000
Tax Credit Carryforward, Amount	39,800,000		39,800,000		39,800,000
Deferred Tax Assets, Gross	12,000,000		12,000,000		12,000,000
Other income		$ 100,000	255,975	506,700	355,975	506,700
Legal Fees					100,000
Deferred Compensation Arrangement with Individual, Distribution Paid					71,250	75,000
Deferred Compensation Arrangement with Individual, Compensation Expense					(472,883)
Current Officer's Plan [Member]
Operating Loss Carryforwards [Line Items]
Deferred Compensation Liability, Current and Noncurrent	$ 2,264,909		2,264,909		2,264,909		$ 2,168,599
Deferred Compensation Arrangement with Individual, Compensation Expense			45,000		96,310
Former Officer [Member]
Operating Loss Carryforwards [Line Items]
Deferred Compensation Liability, Current and Noncurrent							472,883
Deferred Income							$ 472,883
Deferred Compensation Arrangement with Individual, Distribution Paid					71,250
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Income Tax Expense (Benefit)			1,031	2,543	2,062	4,019
Federal [Member]
Operating Loss Carryforwards [Line Items]
Income Tax Expense (Benefit)			$ 0	$ 0	$ 0	$ 0

XML

Inventories (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Inventories [Abstract]
Raw materials	$ 2,227,757	$ 2,067,572
Finished goods	7,312,653	5,621,228
Inventories, gross	9,540,410	7,688,800
Reserve for obsolete inventory	(1,793,961)	(1,787,288)
Inventories, net	$ 7,746,449	$ 5,901,512

XML

Credit Facility and SBA Loan (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
SBA Loan [Member]
Line of Credit Facility [Line Items]
Principal amount			$ 506,700
Town Bank [Member] | Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.00%
Long-term Line of Credit, Total	$ 0	$ 0
Town Bank [Member] | Credit Agreement [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Town Bank [Member] | Credit Agreement [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.50%
Town Bank [Member] | Credit Agreement [Member] | Letter of Credit [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000,000
Town Bank [Member] | Amended Credit Agreement [Member] | Revolving Credit Facility [Member] | Prime Rate [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.50%

XML

Revenue Recognition (Narrative) (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Revenue recognized	$ 335,578	$ 200,424
Deferred revenue liability			$ 593,920
Minimum [Member]
Contract with Customer, Liability, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Maximum [Member]
Contract with Customer, Liability, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	3 years

XML

Revenue Recognition (Disaggregation of Revenue) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net Sales	$ 4,415,886	$ 4,929,789	$ 8,780,953	$ 10,138,084
United States [Member]
Disaggregation of Revenue [Line Items]
Net Sales	3,191,867	3,652,303	6,003,559	7,598,576
Export [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 1,224,019	$ 1,277,486	$ 2,777,394	$ 2,539,508

XML

(Loss) Income Per Common and Common Stock Equivalent Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
(Loss) Income Per Common and Common Stock Equivalent Share [Abstract]
Net (loss) income	$ 578,969	$ 508,890	$ 479,610	$ 635,819
Weighted average shares, basic (in shares)	9,144,099	7,405,758	8,994,023	7,405,295
Dilutive effect of stock compensation awards (in shares)	920,614	47,692	1,068,892	18,944
Diluted shares (in shares)	10,064,713	7,453,450	10,062,915	7,424,239
Basic (in dollars per share)	$ 0.06	$ 0.07	$ 0.05	$ 0.09
Diluted (in dollars per share)	$ 0.06	$ 0.07	$ 0.05	$ 0.09
Anti-dilutive shares	0	2,490,061	0	2,564,584

XML

Related Party Leases (Details)	6 Months Ended
	Dec. 31, 2021 USD ($)
Lessee, Lease, Description [Line Items]
Lease Extension Per Year	$ 380,000
Lessee, Operating Lease, Renewal Term (Year)	5 years
Additional Renewal [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term (Year)	5 years

XML

Accounts Receivable Concentrations (Details) - Customer Concentration Risk [Member]	6 Months Ended
	Dec. 31, 2021 customer
Trade Accounts Receivable [Member] | Company 1 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	24.00%
Trade Accounts Receivable [Member] | Company 2 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	19.00%
Trade Accounts Receivable [Member] | Company 3 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.00%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Number Of Major Customers	3
Accounts Receivable [Member] | Company 1 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	26.00%
Accounts Receivable [Member] | Company 2 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	23.00%
Accounts Receivable [Member] | Company 3 [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	13.00%

XML

Legal Matters (Details)	6 Months Ended
	Dec. 31, 2021 item
Legal Matters [Abstract]
Number of lawsuits	0